GPBAR1 and metabolic disease: In addition to direct effects on the central nervous system function, bile acids might also be involved in the metabolic disorders during CUMS progression by regulating receptor such as FXR (farnesoid X receptor) and TGR5 (Takeda G protein-coupled receptor 5).